264 related articles for article (PubMed ID: 26477849)
1. Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the Republic of Congo.
Francine N; Damien B; Anna F; Michael K; Christevy VJ; Felix KK
Acta Trop; 2016 Jan; 153():111-5. PubMed ID: 26477849
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Cisse M; Sangare I; Lougue G; Bamba S; Bayane D; Guiguemde RT
BMC Infect Dis; 2014 Nov; 14():631. PubMed ID: 25408152
[TBL] [Abstract][Full Text] [Related]
4. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
[TBL] [Abstract][Full Text] [Related]
5. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
[TBL] [Abstract][Full Text] [Related]
7. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
8. Sub-microscopic Plasmodium falciparum infections in matched peripheral, placental and umbilical cord blood samples from asymptomatic Congolese women at delivery.
Mbouamboua Y; Koukouikila-Koussounda F; Ntoumi F; Adukpo S; Kombo M; Vouvoungui C; van Helden J; Kobawila SC
Acta Trop; 2019 May; 193():142-147. PubMed ID: 30836060
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
[TBL] [Abstract][Full Text] [Related]
12. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
13. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
[TBL] [Abstract][Full Text] [Related]
14. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P
Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Tutu EO; Lawson B; Browne E
Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
[TBL] [Abstract][Full Text] [Related]
18. Investigation of pregnancy-associated malaria by microscopy, rapid diagnostic test and PCR in Bandundu, the Democratic Republic of Congo.
Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
Trans R Soc Trop Med Hyg; 2018 Jan; 112(1):8-13. PubMed ID: 29554347
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.
Gutman J; Mwandama D; Wiegand RE; Abdallah J; Iriemenam NC; Shi YP; Mathanga DP; Skarbinski J
Malar J; 2015 May; 14():197. PubMed ID: 25962439
[TBL] [Abstract][Full Text] [Related]
20. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
Taylor SM; Antonia AL; Chaluluka E; Mwapasa V; Feng G; Molyneux ME; ter Kuile FO; Meshnick SR; Rogerson SJ
Clin Infect Dis; 2012 Jul; 55(1):42-50. PubMed ID: 22441649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
